Interventional Cardiologist, SHN🇮🇪 🇨🇦 Previous CTO Fellow, University of Toronto Collab. / Complex PCI fellow, Leeds General Infirmary

Toronto, Ontario
Joined June 2009
Excited for CTO PLUS next week, looking forward to learning the latest in #CTOPCI and finally F2F meeting with leaders in the field #CTO2022 @LeedsHospitals @LeedsPci @ammozid @JenARossington @DrHBulluck @SanjogKalra @evandrofilhobr @AntoniousAttall @MichaelMegalyMD
A Fellow in Complex Coronary Intervention at Yorkshire Heart Centre/@LeedsHospitals, @sparfrey is passionate about #CTOPCI, novel and evolving techniques, intra-coronary imaging, and education. Watch him present his case on 2/24 at #CTO2022. #CardioEd cto2022.crfconnect.com/
3
13
Shane Parfrey retweeted
📣Live Case Spotlight Continues🎥 Oct 4, 4:00 PM! 🍁Watch 2 more live cases - one from @LHSCCanada with Drs. @BElbarouni and @YbarraLuiz and the other from @SHNcares with Drs @A_B_Hall and @sparfrey. Don’t miss it: cancto.ca #CanCTO #ComplexPCI
4
5
654
Shane Parfrey retweeted
Proud to support the @Can_CTO conference and provide radiation protection for the live cases. Special thank you to Ram Vijayaraghavan for leading a great meeting, and to Sanjog Kalra, Bilal Iqbal, Rahul Bhindi, Christopher Li, Shane Parfrey and Vladimír Džavík for showcasing RAMPART ic in the most complex CTO cases and achieving 99%+ radiation attenuation. Thank you to our partners at @OryxMedical for all their efforts to provide radiation solutions and orthopedic protection across Canada. #YouAreWorthIt #ProtectTheTeam @DrBIqbal @SanjogKalra @sparfrey @dzavik_vlad
2
1
5
608
Shane Parfrey retweeted
We proudly present our outstanding Canadian faculty 🇨🇦 attending the CanCTO+Complex PCI Conference, Oct 4-5 in Toronto! Join us to gain insights from some of the brightest minds in the field. Register today at cancto.ca! #CanCTO #ComplexPCI #Cardiology
5
10
1,868
Shane Parfrey retweeted
Safety of rotational atherectomy in #ACS. >2,000 pts undergoing Rota, ✅No difference in Death/MI, slight increase in slow flow. Data suggests safety in selected #ACS, and not an absolute contradiction. Just out in @AmJCardio @DoctorKini @Drroxmehran
1
4
20
1,949
Tune in tomorrow to see Dr Andrew Hogarth on #SavingLives!
"Your heart beats on average around 100,000 times every day. It's quite fascinating how it doesn't go wrong more often." #SavingLives In Leeds | Continues tomorrow at 9pm| BBC Two & BBCiPlayer
9
2
26
4,650
Shane Parfrey retweeted
🔥 data on feasibility and long-term safety of radial artery graft #PCI. A viable alternative to native vessel PCI in #CABG pts. Timely given focus on total arterial revasc! #RadialFirst Congrats @GarryHamilton6 @JulianYeoh1 @drmatiasyudi @JACCJournals – at Bronx, NY
1
3
19
3,466
There's just 1 day to go until the brand-new series of #SavingLives In Leeds begins! 🤩 Watch tomorrow at 9pm on BBC Two & BBCiPlayer.
6
29
3
98
20,565
Shane Parfrey retweeted
Our study just 📖 in @EuroInterventio. Potent P2Y12 agents (ticagrelor, Prasugrel) now used in 1 in 3 patients undergoing stable CAD #PCI. No difference in safety or efficacy compared to clopidogrel @Drroxmehran @DoctorKini @g_giustinoMD @georgedangas – at Mount Sinai, NY
Potent P2Y12 inhibitors, such as prasugrel and ticagrelor, are increasingly used in CCS patients undergoing PCI. In this study, there were no differences between potent P2Y12 inhibitors and clopidogrel in terms of ischemic and bleeding events at one year. ow.ly/rwRn50MvR7Q
1
2
20
2,470
Shane Parfrey retweeted
Interrupting DAPT after 1 month post PCI: Meta-analysis of 4 RCTs, >25000 pts Events between 31days and 1yr: Less bleeding (1.1 vs 1.5%) but no difference in death (1.3 vs 1.6%), MI (1.4 vs 1.2%), ST (0.3 vs 0.2%) or stroke (0.5 vs 0.6%) rdcu.be/cYu7q #cardiotwitter
1
14
27
F-ADR across previously stented anastomoses; this illustration shows the concept and steps nicely.
Replying to @ammozid
Well done @sparfrey on publishing our case series of successful facilitated ADR in patients with prior stented vein graft to native vessel anastomoses Full text link onlinelibrary.wiley.com/shar…
1
18
Shane Parfrey retweeted
Please RT and donate if you can! 30 staff @cardiorespLTHT with family and friends taking on the National 3 Peaks for charity today, driving 450 miles and walking 23miles within 24hrs! Gutted I can't take part - recovering from COVID. Proud of the team! justgiving.com/fundraising/t…
1
12
1
23
Shane Parfrey retweeted
Can #ReCROSS #CTO catheter improve your procedural success in a few years? Nice talk by Dr Mozid in #EuroCTO in #Mainz @CtoEuro
4
3
12
Very excited to be at #BCS2022, lots to see and learn. Very proud to be indirectly representing @cardiorespLTHT and cardiac physiology. Come and say hello!
6
5
21
Shane Parfrey retweeted
Well done to @cardiorespLTHT team at #euroPCR last week. Dr Tim Woodhead presenting this work on our behalf in a session dominated by abstracts from Prof Serruys' lab. See coverage from @TCTMD tctmd.com/news/long-term-out…
1
8
30
A great day of #CT0101 learning for a broad audience with some great talks, tips and live cases #CT02022 #CTO @ammozid @ALadwiniec @jcspratt @simonjwilson1 @Ryvetsprog
2
20
Fantastic session on haemodynamic complications during #CTO #PCI with some great tips and tricks to round off #EuroPCR2022 @PCRonline @KambisMashayek1 @PedroLemosMD @RobertoGarbo1 @MBalghith @guilbon @DrFlorim75
2
8
Shane Parfrey retweeted
Check out the clinical predictors of non-obstructive coronaries in presumed NSTEMI patients from our centre's experience @cardiorespLTH. Interesting work lead by @MTayebjee and colleagues @sparfrey @ammozid @MuruguVee and Joshua Michaels #cardiotwitter heartlungcirc.org/article/S1…
3
9
1
21
Shane Parfrey retweeted
Contemporary tools and devices for coronary calcium modification and the calcium modification algorithm - thanks to @mbmcentegart for the opportunity to co-author this review! journals.sagepub.com/doi/ful… @VP_Med @Jem_Grif @DrPeterOKane @TheBJCA @BCIS_uk @OptimaCTO #CardioTwitter
5
9
43